Fatal OutcomeSurvival RateTreatment OutcomeCell SurvivalRetrospective StudiesPrognosisSurvival AnalysisRisk FactorsInfant, NewbornTime FactorsFollow-Up StudiesOutcome Assessment (Health Care)Disease-Free SurvivalProspective StudiesBacteremiaSurvivalSeverity of Illness IndexFasciitis, NecrotizingAcute DiseaseGraft SurvivalSepsisMeningitis, MeningococcalMeningococcal InfectionsMultiple Organ FailurePregnancy OutcomeAge FactorsPostoperative ComplicationsMultivariate AnalysisPredictive Value of TestsPneumonia, BacterialIncidenceShock, SepticAutopsyDisease ProgressionKaplan-Meier EstimatePregnancyTomography, X-Ray ComputedAnti-Bacterial AgentsPancreatitisDisease OutbreaksBiological MarkersPneumoniaProportional Hazards ModelsStreptococcal InfectionsInfluenza, HumanNeoplasm StagingCohort StudiesBrainOutcome and Process Assessment (Health Care)Combined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsLungRecurrenceRisk AssessmentTumor Necrosis Factor-alphaNeoplasm Recurrence, LocalApoptosisBreast NeoplasmsUnited StatesRegistriesRandomized Controlled Trials as TopicLung NeoplasmsTumor Markers, BiologicalAntineoplastic AgentsQuality of LifeImmunohistochemistrySignal TransductionAdenocarcinomaLogistic ModelsChi-Square DistributionCell Line, TumorNeoplasm MetastasisChemotherapy, AdjuvantReoperationGlasgow Outcome ScaleNeoplasmsRegression AnalysisBrain NeoplasmsLiver NeoplasmsRecovery of FunctionTransplantation, HomologousAnalysis of VariancePatient SelectionLength of StayHospital MortalityMice, Inbred C57BLKidney TransplantationLiver TransplantationGraft RejectionStrokeCell ProliferationCisplatinTreatment FailureRemission InductionColorectal NeoplasmsCyclophosphamideClinical Trials as TopicLongitudinal StudiesSex FactorsPatient Outcome Assessment